Serum levels of bone alkaline phosphatase in breast and prostate cancers with bone metastasis

Garnero P. and Deimas, P.D. (1993) Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J. Clin. Endocrinol. Metabolism 77, 1046–1053. Fishman, W.H. (1990) Alkaline phosphatase isozymes: recent progress (Review). Clin. Biochem. 23, 99–104. Fedde, K.N. (1992) Human osteosarcoma cells spontaneously release matrix-vesicle-like structures with the capacity to mineralize. Bone. Miner. 17, 145–151. Faley, J. and Bayliunk, D. (1986) Skeletal alkaline phosphatase activity as a bone formation index in vitro. Metabolism 35, 563–571. Van Straalen, J.P., Sanders, E., Prummel, M.F. and Sanders, G.T.B. (1991) Bone alkaline phosphatase as a indicator of bone formation. Clin. Chim. Acta. 201, 27–34. Kress, B.C., Mizrahi, I.A., Armour, K.W., Mareus, R., Emkey, R.D. and Santora, A.C. (1999) Use of Bone Alkaline Phosphatase to monitor Alendronate therapy in individual postmenopausal osteoporetic women. Clin. Chem. 45, 1009–1017. Meijer, W.G., Van Der Veer, E. and Willemse, P.H.B. (1998) Biochemical parameters of bone metabolism in bone metastases of solid tumors (Review), Oncol. Rep. 5(1), 5–21. Van Hoof, V.O., Van Oosterom, A.T., Lepoutre, L.G. and de Broe, M.E. (1992) Alkaline phosphatase isoenzyme patterns in malignancy disease. Clin. Chem. 38, 2546–2551. Stieber, P., Nagel, D., Ritzke, C., Rossler, N., Kirsch, C.M. and Eiermann, W. (1992) Significance of bone alkaline phosphatase, CA 15-3 and CEA in the detection of bone metastases during follow up of patients suffering from breast carcinoma. Eur. J. Clin. Chem. Clin. Biochem. 30, 809–814. Burlina, A., Rubin, D., Secchiero, S., Sciacovelli, L., Zaninotto, M. and Plebani, M. (1994) Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase. Clin. Chim. Acta 226, 151–158. Withold, W., Schulte, U. and Reinauer, H. (1996) Method for determination of bone alkaline phosphatase activity: analytical performance and clinical usefulness in patients with metabolic and malignant bone diseases. Clin. Chem. 42, 210–217. Behr, W. and Bamert, J. (1986) Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility. Clin. Chem. 32, 1960–1966. Lorente, J.A., Valenzuela, H., Morote, J. and Gelabert, A. (1999) Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients. Eur. J. Nucl. Med. 26(6), 625–632. Wolff, J.M., Ittel, T.H., Borchers, H., Boekels, O. and Jakse, G. (1999). Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase. Anticancer Res. 19(4A), 2653–2655. Berruti, A., Dogliotti, L., Gorzegno, G., Torta, M., Tampellini, M., Tucci, M., Cerutti, S., Frezet, M.M., Stivanello, M., Sacchetto, G. and Angeli, A. (1999) Differential patterns of bone turnover in relation to bone pain and disease extent in bone cancer patients with skeletal metastases. Clin. Chem. 45(8), 1240–1247. Akimoto, S., Furuya, Y., Akakura, K. and Ito, H. (1998) Comparison of markers of bone formation and resorption in prostate cancer patients to predict bone metastasis. Endocr. J. 45(1), 97–104. Diaz Martin, M.A., Traba, M.L., De la Piedra, C., Guerrero, R., Mendez Davila, C. and Garcia De La Pena, E. (1999) Aminoterminal propeptide of type I collagen and bone alkaline phosphatase in the study of bone metastases associated with prostatic carcinoma. Scand. J. Clin. Lab. Invest. 59(2), 125–132.